Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
JAK Inhibitors
Would you consider prescribing a JAK inhibitor for a patient with a history of DVT who is on chronic anticoagulation, or would the thrombotic risk deter you?
Related Questions
How do you assess the potential role of obesity in driving inflammatory joint symptoms?
How can we approach tapering or discontinuing biologic DMARDs in patient in their 80s with well controlled rheumatoid arthritis?
How do you approach management of RA in patients who have developed anti-drug antibodies to infliximab, especially if use of methotrexate is contraindicated and patients have tried and failed several other biologics?
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
How do you taper corticotropin injections (Acthar) in patients with rheumatologic disease?
What factors would encourage you to choose abatacept vs tocilizumab in a patient with RA-ILD with a UIP pattern of pulmonary fibrosis?
How would you approach management of a patient with seropositive RA and UIP-ILD, with concern for active lung disease?
How would you approach managing a patient with well-controlled RA on abatacept who develops a solid malignancy?
How do you approach dyspnea in a patient with seropositive rheumatoid arthritis with normal imaging findings but abnormal PFT findings (restriction, reduced DLCO)?
What is your typical steroid taper regimen for managing RA flares?
